Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Community Based Trial for AMEVIVE®

ClinicalTrials.gov ID: NCT00168753

Public ClinicalTrials.gov record NCT00168753. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 1:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Community-Based Study to Determine the Safety and Efficacy of an Extended Course of Alefacept, Following a Standard 12-Week Course of Amevive®, With Commonly Used Clinical Assessment Tools

Study identification

NCT ID
NCT00168753
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Astellas Pharma Inc
Industry
Enrollment
114 participants

Conditions and interventions

Interventions

  • Alefacept Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2004
Primary completion
Feb 28, 2005
Completion
Feb 28, 2005
Last update posted
Sep 7, 2014

2004 – 2005

United States locations

U.S. sites
36
U.S. states
23
U.S. cities
36
Facility City State ZIP Site status
Monheit Dermatology Associates Birmingham Alabama 35203
Bayshore Dermatology Fairhope Alabama 36532
Jayne Fortson Anchorage Alaska 99501
Bakersfield Dermatology & Skin Cancer Medical Group Bakersfield California 93301
Integrated Research Group Riverside California 92501
Robert Greenberg San Ramon California 94582
Front Dermatology Denver Colorado 80014
Skin and Cancer Associates Tamarac Florida 33309
Michael Scannon Tampa Florida 33602
Atlanta Derm, Vein & Research Center Alpharetta Georgia 30004
Pearlridge Dermatology ‘Aiea Hawaii 96701
Altman Dermatology Associates Arlington Heights Illinois 60004
Calumet Dermatology Associates Calumet City Illinois 60477
Michael Greenberg Elk Grove Village Illinois 60007
David J. Coynik Peru Illinois 61354
Melissa Knuckles Corbin Kentucky 40701
Richard Eisen Plymouth Massachusetts 02360
Psoriasis Treatment Center Grand Rapids Michigan 49503
Woodson Clinical Studies Group, Inc. Las Vegas Nevada 89101
Nashua Dermatology Nashua New Hampshire 03060
Jerry Bagel East Windsor New Jersey 08512
Catskill Dermatology Monticello New York 12701
Marina I Peredo Smithtown New York 11787
Buffalo Medical Group Williamsville New York 14221
Wilmington Health Associates Dermatology Wilmington North Carolina 28401
Robert Brodell Warren Ohio 44481
Dermatology & Laser Center of Roseberg Roseburg Oregon 97470
Dermatology Assoc of Plymouth Meeting Plymouth Meeting Pennsylvania 19462
Dermatology Associates of Knoxville Knoxville Tennessee 37902
Gold Skin Care Nashville Tennessee 37201
Bellaire Dermatology Associates Bellaire Texas 77401
Texas Dermatology Research Dallas Texas 75201
Mark Wallis Longview Texas 75601
Stephen Miller San Antonio Texas 78201
Stephen Flax Winchester Virginia 22601
Dermatology & Laser Center Bellingham Washington 98225

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00168753, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 7, 2014 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00168753 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →